These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 39188755)

  • 1. Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products.
    Castenmiller SM; Kanagasabesan N; Guislain A; Nicolet BP; van Loenen MM; Monkhorst K; Veenhof AAFA; Smit EF; Hartemink KJ; Haanen JBAG; de Groot R; Wolkers MC
    Oncoimmunology; 2024; 13(1):2392898. PubMed ID: 39188755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Jiménez-Reinoso A; Molero-Abraham M; Cirauqui C; Blanco B; Garrido-Martin EM; Nehme-Álvarez D; Domínguez-Alonso C; Ramírez-Fernández Á; Díez-Alonso L; Nuñez-Buiza Á; González-Murillo Á; Tobes R; Pareja E; Ramírez-Orellana M; Rodriguez-Peralto JL; Ferrer I; Zugazagoitia J; Paz-Ares L; Álvarez-Vallina L
    Oncoimmunology; 2024; 13(1):2392897. PubMed ID: 39206095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.
    Xin S; Wen S; He P; Zhao Y; Zhao H
    Front Immunol; 2024; 15():1423775. PubMed ID: 39192984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
    Ben-Avi R; Farhi R; Ben-Nun A; Gorodner M; Greenberg E; Markel G; Schachter J; Itzhaki O; Besser MJ
    Cancer Immunol Immunother; 2018 Aug; 67(8):1221-1230. PubMed ID: 29845338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.
    Berthe J; Poudel P; Segerer FJ; Jennings EC; Ng F; Surace M; Andoni A; Testori M; Saraiya M; Vuko M; Hessel H; Heininen-Brown M; Blando J; Jones EV; Willis SE; Galon J; van de Ven R; de Gruijl TD; Angell HK
    Front Immunol; 2024; 15():1422206. PubMed ID: 39376565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
    Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
    Front Immunol; 2021; 12():626776. PubMed ID: 33763071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-negative (CD27
    Centuori SM; Gomes CJ; Kim SS; Putnam CW; Larsen BT; Garland LL; Mount DW; Martinez JD
    J Transl Med; 2018 Feb; 16(1):30. PubMed ID: 29448960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.
    Kroeger DR; Milne K; Nelson BH
    Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
    Shah P; Forget MA; Frank ML; Jiang P; Sakellariou-Thompson D; Federico L; Khairullah R; Neutzler CA; Wistuba I; Chow CB; Long Y; Fujimoto J; Lin SY; Maitra A; Negrao MV; Mitchell KG; Weissferdt A; Vaporciyan AA; Cascone T; Roth JA; Zhang J; Sepesi B; Gibbons DL; Heymach JV; Haymaker CL; McGrail DJ; Reuben A; Bernatchez C
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A
    Zhang D; Jiang D; Jiang L; Ma J; Wang X; Xu X; Chen Z; Jiang M; Ye W; Wang J; Meng W; Qiu W; Hou Y; Huang J; Jiao Y; Liu Y; Liu Z
    Br J Cancer; 2024 Jul; 131(1):184-195. PubMed ID: 38762674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile.
    De Groot R; Van Loenen MM; Guislain A; Nicolet BP; Freen-Van Heeren JJ; Verhagen OJHM; Van Den Heuvel MM; De Jong J; Burger P; Van Der Schoot CE; Spaapen RM; Amsen D; Haanen JBAG; Monkhorst K; Hartemink KJ; Wolkers MC
    Oncoimmunology; 2019; 8(11):e1648170. PubMed ID: 31646094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic analysis of tumor-infiltrating lymphocytes from non-small cell lung cancer and their potential application for adoptive cell therapy.
    Ma Y; Ou J; Lin T; Chen L; Wang J; Qiao D; Lai S; Duan C; Cheng Y; Chang R; Zhang C; Wang M
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):319-329. PubMed ID: 32419542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
    Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
    Front Immunol; 2020; 11():2105. PubMed ID: 33013886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production.
    van Asten SD; de Groot R; van Loenen MM; Castenmiller SM; de Jong J; Monkhorst K; Haanen JBAG; Amsen D; Bex A; Spaapen RM; Wolkers MC
    Oncoimmunology; 2021 Jan; 10(1):1860482. PubMed ID: 33537169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
    Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.
    Buisseret L; Desmedt C; Garaud S; Fornili M; Wang X; Van den Eyden G; de Wind A; Duquenne S; Boisson A; Naveaux C; Rothé F; Rorive S; Decaestecker C; Larsimont D; Piccart-Gebhart M; Biganzoli E; Sotiriou C; Willard-Gallo K
    Mod Pathol; 2017 Sep; 30(9):1204-1212. PubMed ID: 28621322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
    Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
    BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.